ClinVar Miner

Submissions for variant NM_002230.4(JUP):c.266T>C (p.Met89Thr)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000707335 SCV000836427 uncertain significance Naxos disease; Arrhythmogenic right ventricular cardiomyopathy, type 12 2018-03-13 criteria provided, single submitter clinical testing This sequence change replaces methionine with threonine at codon 89 of the JUP protein (p.Met89Thr). The methionine residue is moderately conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is present in population databases (rs542745694, ExAC 0.05%). This variant has not been reported in the literature in individuals with JUP-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Stanford Center for Inherited Cardiovascular Disease,Stanford University RCV000786330 SCV000925105 uncertain significance not provided 2017-04-21 no assertion criteria provided provider interpretation This patient has a diagnosis of HCM and had a Comprehensive Cardiomyopathy Panel with the GeneDx laboratory. The test included sequencing of 76 genes and additional deletion/duplication analysis of 60 of those genes (nuclear genes) associated with various forms of cardiomyopathy: ABCC9, ACTC (ACTC1), ACTN2, ANKRD1, BAG3 , BRAF, CAV3, CRYAB, CSRP3, DES, DMD, DSC2, DSG2, DSP, DTNA, EMD, FKTN, GATAD1, GLA, HRAS, ILK, JPH2, JUP, KRAS, LAMA4, LAMP2, LDB3 (ZASP), LMNA, MAP2K1, MAP2K2, MTND1, MTND5, MTND6, MTTD, MTTG, MTTH, MTTI, MTTK, MTTL1, MTTL2, MTTM, MTTQ, MTTS1, MTTS2, MYBPC3, MYH7, MYL2, MYL3, MYLK2, MYOZ2, MYPN, NEBL , NEXN, NRAS, PDLIM3, PKP2, PLN, PRKAG2, PTPN11, RAF1, RBM20, RYR2, SCN5A, SGCD, SOS1, TAZ, TCAP, TMEM43, TMPO, TNNC1, TNNI3, TNNT2, TPM1, TTN, TTR, VCL. 7 variants were reported. We believe the MYH7 variant is the most likely to be pathogenic: • p.Ala868Pro (A868P; c.2602G>C) in the MYH7 gene • p.Leu327Val (L327V; c.979C>G) in the PRKAG2 gene • p.Pro323Thr (P323T; c.967C>A) in the GLA gene • p.Ala749Ile (A749I; c.2245_2246delGCinsAT) in the PKP2 gene • p.Met89Thr (M89T; c.266T>C) in the JUP gene • p.Asp2771Ala (D2771A; c.8312A>C) in the DMD gene • Duplication of at least exons 1-2 of the LAMA4 gene Given the large number of genes included on this panel, and the large and variable nature of some of these genes, it is expected that most individuals (including individuals who don't have inherited cardiac disease) would have at least one and possibly several rare variants found with this test. As a result, it is important to consider the data available on each variant to determine whether it is a disease-predisposing variant or one of the many benign rare variants that we all have in our DNA. p.Met89Thr (M89T; c.266T>C) in exon 3 of the JUP gene (NM_002230.2; ENST00000393931.7) Chromosome position: 17:39925872 A / G Based on the information reviewed below, including lack of case data, we classify it as a Variant of Uncertain Signficance (VUS), concluding that there is not sufficient evidence for its pathogenicity to warrant using it for predictive genetic testing. Because of its increased prevalence among individuals with Latino ancestry (like our patient), we suspect that it is more likely to be benign. Of note, the JUP gene is associated with ARVC, which is not our patient’s phenotype. This variant has not been reported in the literature in association with disease. This is a nonconservative amino acid change, resulting in the replacement of a nonpolar Methionine with a polar Threonine. Methionine at this location is highly conserved across vertebrate species, although it is replaced by another nonpolar amino acid in a few species. There are no missense variants within 10 residues currently listed as Pathogenic or Likely Pathogenic in ClinVar, which suggests this region of the protein may be tolerant of change. This variant was reported in 12/113,726 individuals (MAF 0.005%) in the gnomAD database, which includes ~140,000 individuals of European, African, Latino, South Asian, Ashkenazi, and East Asian descent. Specifically, the variant was observed in 10/15,634 Latino individuals (for the highest allele frequency: 0.032%), and 2/51,540 non-Finnish Europeans (MAF 0.002%). The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. The curators made an effort to exclude individuals with severe pediatric diseases. Of note, our patient’s ancestry is Latino.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.